Geftib 250 mg Tablet

Description

Geftib 250 mg Tablet is an antineoplastic medication classified as a tyrosine kinase inhibitor, with Gefitinib as its active ingredient. It is primarily prescribed for the treatment of non-small cell lung cancer (NSCLC), a type of lung cancer characterized by the uncontrolled and abnormal growth of cells in lung tissue. This medicine is specifically used in patients whose cancer has spread (metastasized) to other parts of the body, particularly those with abnormal EGFR (epidermal growth factor receptor) gene mutations, and who have not received prior cancer treatment. Specific formulations of Geftib may contain lactose as an inactive ingredient. Individuals with lactose intolerance, a condition in which the body is unable to digest lactose, a sugar found in milk, may experience symptoms such as bloating, gas, and abdominal discomfort. It is important to inform your doctor if you have lac